New Targets Sample Clauses

New Targets. 8 2.3 [ * ].................................................... 8 2.4 [ * ].................................................... 8 2.5 Exclusivity/Third Party Agreements....................... 9 2.5.1 Exclusivity.............................................. 9 2.5.2 Activities Relating to the Field......................... 9 2.5.3 Joint Decision-Making Process............................ 9 2.5.4 Re-Presentation to Officers.............................. 10 2.5.5 Outside Activities.......................................
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
New Targets. If a Target is discovered as part of the Research Collaboration, the Party discovering such new Target shall notify the Research Management Committee. At the next Research Management Committee meeting, the parties shall discuss such new Target. If the Research Management Committee decides that the new Target should be included in the Research Collaboration, then Roche Bioscience shall disclose whether the Target is under investigation by another Roche research site. If the new Target is not under investigation by Roche at such time, such new Target shall be included in the Research Collaboration. If the new Target is under investigation by Roche at such time, Roche Bioscience shall notify Tularik in writing within sixty (60) days of such Research Management Committee meeting whether Roche Bioscience shall (a) exclude such Target from the Research Collaboration and the definition of "Target" or (b) include such Target in the Research Collaboration. If the Research Management Committee or Roche Bioscience elects to exclude such Target from the Research Collaboration, then each Party may pursue HTS, development and commercialization activities against such Target outside of the Research Collaboration subject to any proprietary rights of the other Party (including its Affiliates) or any Third Party; provided, however, that the Party that did not discover such Target shall not use any information developed during the Research Collaboration with respect to such Target; and provided, further, that the Party discovering such Target may not license it to a Third Party during the Research Term and applicable Tail Period, if any. If Roche bioscience elects to include such Target in the Research Collaboration, then it shall be treated as a Shared Target (as defined below).
Sample 1Sample 2
New Targets. 2.7.1 Tularik may, in its sole discretion, (i) [ * ] New Target Candidates; (ii) [ * ] to determine whether compounds from the Tularik Compound Library agonize and/or antagonize such New Target Candidates; and/or (iii) [ * ] with respect to compounds that agonize and/or antagonize such New Target Candidates. In the event Tularik determines, in its sole discretion, to [ * ] as of the Effective Date, the opportunity: (A) to [ * ] a New Target Candidate (a "Research Opportunity"); or (B) to [ * ] a New Target Candidate (a "Compound Opportunity"); Tularik shall [ * ] in a written notice reasonably describing such [ * ], or such [ * ] shall have no obligation to offer to Xxxxx any: (Y) [ * ]; or (Z) [ * ]; in which case Tularik shall [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of this Securities Act of 1933, as amended. be obligated to offer to Xxxxx such [ * ] or such Compound Opportunity that relates to such compound that [ * ]. 2.7.2 In the event Tularik offers to Xxxxx a Research Opportunity pursuant to Section 2.7.1, Xxxxx shall, within [ * ] of receipt of such written notice, inform Tularik in writing whether Xxxxx: (i) wishes to [ * ]; (ii) wishes to [ * ]; or (iii) does not wish to [ * ]. 2.7.3 In the event Xxxxx elects the option contained in Section 2.7.2(i) above, and the Research Opportunity relates to a New Target Candidate that is not a [ * ], (i) Xxxxx shall pay Tularik [ * ] upon signing of the amended Appendix A and (ii) Xxxxx shall [ * ], and such New Target Candidate shall be added to Appendix A as [ * ]; 2.7.4 In the event Xxxxx elects the option contained in Section 2.7.2(i) above, and the Research Opportunity relates to a New Target Candidate that is a [ * ], Xxxxx shall [ * ] and such New Target Candidate shall be added to Appendix A as [ * ]; 2.7.5 In the event Xxxxx elects the option contained in Section 2.7.2(ii) above, Xxxxx shall not be required to [ * ] such New Target Candidate and such New Target Candidate shall be added to Appendix A as [ * ]. Upon addition of a New Target Candidate to Appendix A as a [ * ], one of the then-Current Program Targets selected by the RC shall be [ * ] and Tularik may [ * ], both within and outside of the Field, resulting from research relating to such Current Program Target that has been deleted from Appendix A, either alone or with any Third Party, [ * ]...
Sample 1
New Targets. (A) The two (2) initial New Targets in the Inflammation Therapeutic Area mutually agreed by the Parties as of the Amendment No. 2 Execution Date are [***] and [***] (each, an “Initial New Target”). (B) Notwithstanding Section 2.5(b)(i)(B), [***] following the Amendment No. 2 Execution Date, the Parties will collaborate to identify up to two (2) additional Targets and the Therapeutic Area for each such additional Target, in each case as may be mutually agreed by the Parties in writing (each, an “Additional New Target”); [***].
Sample 1
New Targets. If a Target is discovered as part of the Research Collaboration, the Party discovering such new Target shall notify the Research Management Committee. At the next Research Management Committee meeting, the parties shall discuss such new Target. If the Research Management Committee decides that the new Target should be included in the Research Collaboration, then Roche Bioscience shall [ * ]. If the new Target is not [ * ] at such time, such new Target shall be [ * ]. If the new Target is [ * ] at such time, Roche Bioscience shall [ * ]. If the Research Management Committee or Roche Bioscience elects to [ * ], then each Party may [ * ] of the other Party (including its Affiliates) or any Third Party; provided, however, that the Party that did not discover such Target shall not [ * ].
Sample 1
New Targets. (a) During the Reserved Target Exclusivity Period, Ultragenyx shall have the right to replace each Reserved Target with a proposed new Target by providing Arcturus with written notice thereof; provided that as of the time Ultragenyx provides such notification, (i) Arcturus has not already granted an option or a license to any Third Party to
Sample 1
New Targets. The targets agreed for the coming year are derived directly from the performance areas of the UFO profile and the organisational and/or departmental goals. For academic staff, agreements regarding knowledge valorisation and management tasks will also be included in the targets, in addition to agreements on education and research;
Sample 1
AutoNDA by SimpleDocs

Related to New Targets

  • Targets Seller’s supplier diversity spending target for Work supporting the construction of the Project prior to the Commercial Operation Date is ____ percent (___%) as measured relative to Seller’s total expenditures on construction of the Project prior to the Commercial Operation Date, and;

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving (either itself or through the acts of a SUBLICENSEE) the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Targets and Milestones You may choose to develop specific additional targets and milestones which assess your performance in ITT over time – particularly if ITT trainees make up a significant proportion of your overall student body. Alternatively, you may have targets and milestones in your existing 2012-13 access agreement which you now also wish to apply to undergraduate and/or postgraduate ITT trainees. These targets may be statistical – based on how representative your entrants are and/or your retention performance – and might include annual or interim milestones to help you monitor whether you are making progress. You may wish to include criteria around the numbers of trainees in receipt of a full or partial maintenance grant, as financial data will need to be collected to determine bursary support and the data will also be accessible through the Student Loans Company for HEBSS subscribers. You may also wish to consider the TDA guidance at Annex C which gives information on specific groups that are underrepresented in the teaching profession.

  • Performance Targets Threshold, target and maximum performance levels for each performance measure of the performance period are contained in Appendix B.

  • Evaluation Criteria 5.2.1. The responses will be evaluated based on the following: (edit evaluation criteria below as appropriate for your project)

  • Project Specific Milestones In addition to the milestones stated in Section 212.5 of the Tariff, as applicable, during the term of this ISA, Interconnection Customer shall ensure that it meets each of the following development milestones: 6.1 Substantial Site work completed. On or before December 31, 2020 Interconnection Customer must demonstrate completion of at least 20% of project site construction. At this time, Interconnection Customer must submit to Interconnected Transmission Owner and Transmission Provider initial drawings, certified by a professional engineer, of the Customer Interconnection Facilities. 6.2 Delivery of major electrical equipment. On or before December 31, 2021, Interconnection Customer must demonstrate that all generating units have been delivered to Interconnection Customer’s project site.

  • Milestones Subject to the provisions of the SGIP, the Parties shall agree on milestones for which each Party is responsible and list them in Attachment 4 of this Agreement. A Party’s obligations under this provision may be extended by agreement. If a Party anticipates that it will be unable to meet a milestone for any reason other than a Force Majeure event, it shall immediately notify the other Parties of the reason(s) for not meeting the milestone and (1) propose the earliest reasonable alternate date by which it can attain this and future milestones, and (2) requesting appropriate amendments to Attachment 4. The Party affected by the failure to meet a milestone shall not unreasonably withhold agreement to such an amendment unless it will suffer significant uncompensated economic or operational harm from the delay, (1) attainment of the same milestone has previously been delayed, or (2) it has reason to believe that the delay in meeting the milestone is intentional or unwarranted notwithstanding the circumstances explained by the Party proposing the amendment.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Project Goals The schedule, budget, physical, technical and other objectives for the Project shall be defined.

  • Program Objectives Implement a rigorous constructability program following The University of Texas System, Office of Facilities Planning and Construction Constructability Manual. Identify and document project cost and schedule savings (targeted costs are 5% of construction costs). Clarification of project goals, objectives.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!